Adaptation of Individual Dialectical Behavior Therapy Intervention for Transdiagnostic Treatment of Emotional Disorders
Launched by MACKAY MEMORIAL HOSPITAL · Aug 9, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a special type of therapy called modified Dialectical Behavior Therapy (DBT) to see if it helps people with anxiety and depression, which are common emotional disorders. The researchers want to find out if this therapy can improve patients' mental health, daily functioning, and overall quality of life. They are particularly interested in how well this therapy works for different types of emotional disorders and aim to gather data over three years in Taiwan, where little research has been done in this area.
To participate in this trial, individuals need to be between 16 and 74 years old, speak Mandarin Chinese well enough to answer study questions, and have a current diagnosis of anxiety or depression. However, those with certain conditions, such as severe mental illnesses or those who have recently changed their medication, are not eligible. Participants can expect to receive the modified DBT treatment and will be monitored closely throughout the study. This trial represents an important step in exploring new treatment options for emotional disorders in the region.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Mandarin Chinese-language proficiency sufficient to complete study questionnaire
- • 2. A current diagnosis of depressive or anxiety disorder as diagnosed from a SCAN interview
- Exclusion Criteria:
- • 1. Intellectual disability
- • 2. Substance use disorder in the past three months
- • 3. Bipolar disorder
- • 4. Psychotic disorder
- • 5. Organic brain disorder
- • 6. Acute suicidality or a history of frequent or recent suicide attempts
- • 7. Recent (past six weeks) change in psychiatric medication or unwillingness to maintain a stable dosage of medication during study participation
- • 8. Had received five or more sessions of CBT in the past five years or unwilling to stop concurrent psychotherapy for an emotional disorder
- • 9. Any mental or physical condition requiring hospital admission
- • 10. Another medical condition likely to prevent participation in the study
About Mackay Memorial Hospital
Mackay Memorial Hospital is a leading healthcare institution dedicated to advancing medical science through innovative clinical research. With a commitment to patient-centered care, the hospital actively sponsors and conducts clinical trials across various therapeutic areas, aiming to develop new treatment options and improve health outcomes. Boasting a team of experienced researchers and healthcare professionals, Mackay Memorial Hospital adheres to rigorous ethical standards and regulatory guidelines, ensuring the safety and well-being of participants while contributing to the global body of medical knowledge. Its collaborative approach fosters partnerships with academic institutions and industry leaders, positioning it as a key player in the advancement of healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Trial Officials
Shen-Ing Liu, Ph.D
Principal Investigator
Mackay Memorial Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported